American Academy of Pediatrics

TABLE 2

PRs and aPRs for Substance-Use Outcomes and Protective Factors

	Future Orientation			Parental Monitoring			Social Support			School Connectedness
	PR (95% CI)^b	aPR^a (95% CI)	P	PR (95% CI)	aPR^a (95% CI)	P	PR (95% CI)	aPR^a (95% CI)	P	PR (95% CI)	aPR^a (95% CI)	P
Vaping
Recent vaping^b (past 30 d)	0.76 (0.65–0.88)	0.84 (0.73–0.97)	.02	0.54 (0.45–0.64)	0.73 (0.62–0.85)	<.001	1.03 (0.90–1.17)	1.04 (0.91–1.18)	.60	0.87 (0.75–1.02)	0.94 (0.82–1.08)	.38
Lifetime vaping^b	0.81 (0.73–0.90)	0.90 (0.81–0.99)	.03	0.64 (0.58–0.72)	0.82 (0.74–0.90)	<.001	0.93 (0.85–1.02)	0.96 (0.88–1.04)	.27	0.88 (0.80–0.98)	0.95 (0.86–1.03)	.22
Other tobacco use
Recent cigarette smoking (past 30 d)	0.37 (0.27–0.52)	0.48 (0.34–0.69)	<.001	0.23 (0.13–0.40)	0.36 (0.21–0.64)	<.001	0.50 (0.36–0.69)	0.57 (0.41–0.79)	<.001	0.42 (0.26–0.67)	0.46 (0.29–0.75)	.002
Smokeless tobacco (past 30 d)	0.30 (0.16–0.55)	0.46 (0.24–0.90)	.02	0.08 (0.02–0.34)	0.19 (0.04–0.79)	.02	0.26 (0.14–0.47)	0.32 (0.17–0.62)	<.001	0.20 (0.07–0.55)	0.24 (0.08–0.70)	.009
Cigars or cigarillos (past 30 d)	0.37 (0.26–0.53)	0.46 (0.32–0.68)	<.001	0.20 (0.11–0.37)	0.35 (0.19–0.63)	<.001	0.51 (0.36–0.70)	0.62 (0.45–0.87)	.006	0.69 (0.47–1.03)	0.80 (0.54–1.19)	.27
Lifetime cigarette smoking	0.63 (0.53–0.75)	0.73 (0.62–0.87)	<.001	0.47 (0.38–0.59)	0.62 (0.50–0.77)	<.001	0.69 (0.59–0.81)	0.77 (0.66–0.90)	<.001	0.60 (0.49–0.74)	0.67 (0.54–0.82)	<.001
Intentions to quit
Intent to quit tobacco product use (past 12 mo)^c	0.95 (0.75–1.21)	0.97 (0.75–1.25)	.80	1.06 (0.81–1.40)	1.10 (0.83–1.46)	.49	0.93 (0.75–1.15)	0.95 (0.76–1.19)	.67	0.89 (0.69–1.16)	0.92 (0.70–21)	.55

	Future Orientation			Parental Monitoring			Social Support			School Connectedness
	PR (95% CI)^b	aPR^a (95% CI)	P	PR (95% CI)	aPR^a (95% CI)	P	PR (95% CI)	aPR^a (95% CI)	P	PR (95% CI)	aPR^a (95% CI)	P
Vaping
Recent vaping^b (past 30 d)	0.76 (0.65–0.88)	0.84 (0.73–0.97)	.02	0.54 (0.45–0.64)	0.73 (0.62–0.85)	<.001	1.03 (0.90–1.17)	1.04 (0.91–1.18)	.60	0.87 (0.75–1.02)	0.94 (0.82–1.08)	.38
Lifetime vaping^b	0.81 (0.73–0.90)	0.90 (0.81–0.99)	.03	0.64 (0.58–0.72)	0.82 (0.74–0.90)	<.001	0.93 (0.85–1.02)	0.96 (0.88–1.04)	.27	0.88 (0.80–0.98)	0.95 (0.86–1.03)	.22
Other tobacco use
Recent cigarette smoking (past 30 d)	0.37 (0.27–0.52)	0.48 (0.34–0.69)	<.001	0.23 (0.13–0.40)	0.36 (0.21–0.64)	<.001	0.50 (0.36–0.69)	0.57 (0.41–0.79)	<.001	0.42 (0.26–0.67)	0.46 (0.29–0.75)	.002
Smokeless tobacco (past 30 d)	0.30 (0.16–0.55)	0.46 (0.24–0.90)	.02	0.08 (0.02–0.34)	0.19 (0.04–0.79)	.02	0.26 (0.14–0.47)	0.32 (0.17–0.62)	<.001	0.20 (0.07–0.55)	0.24 (0.08–0.70)	.009
Cigars or cigarillos (past 30 d)	0.37 (0.26–0.53)	0.46 (0.32–0.68)	<.001	0.20 (0.11–0.37)	0.35 (0.19–0.63)	<.001	0.51 (0.36–0.70)	0.62 (0.45–0.87)	.006	0.69 (0.47–1.03)	0.80 (0.54–1.19)	.27
Lifetime cigarette smoking	0.63 (0.53–0.75)	0.73 (0.62–0.87)	<.001	0.47 (0.38–0.59)	0.62 (0.50–0.77)	<.001	0.69 (0.59–0.81)	0.77 (0.66–0.90)	<.001	0.60 (0.49–0.74)	0.67 (0.54–0.82)	<.001
Intentions to quit
Intent to quit tobacco product use (past 12 mo)^c	0.95 (0.75–1.21)	0.97 (0.75–1.25)	.80	1.06 (0.81–1.40)	1.10 (0.83–1.46)	.49	0.93 (0.75–1.15)	0.95 (0.76–1.19)	.67	0.89 (0.69–1.16)	0.92 (0.70–21)	.55

PR, prevalence ratio.

Poisson regression models adjusted for age, sex assigned at birth, race and ethnicity, identification as sexual or gender minority, and other substance use. Results are reported as prevalence ratios; robust SEs were used to compute 95% CIs.

Electronic vapor products included e-cigarettes, electronic cigars, electronic pipes, vape pipes, vaping pens, electronic hookahs, and hookah pens (examples: blu, NJOY, Vuse, MarkTen, Logic, Vapin Plus, eGo, and Halo).

Individuals responding “I did not use any tobacco products in the last 12 months” were not included in this item’s analysis.

View Large

This Feature Is Available To Subscribers Only